CRISPR THERAPEUTICS AG (CRSP) Stock Income Statement
NASDAQ:CRSP - Nasdaq - CH0334081137 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 37.67M | 37.31M | 371.21M | 1.20M | 915.00M | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 512.08M | 503.88M | 593.74M | 674.40M | 541.40M | |||
| Research and Development | 316.96M | 320.65M | 387.33M | 461.60M | 438.60M | |||
| Selling, General, and Administrative Expenses | 195.11M | 183.23M | 206.41M | 212.70M | 102.80M | |||
| Operating Income | -474.40M | -466.57M | -222.54M | -673.20M | 373.50M | |||
| Interest Income/Expense | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Income/Expense | 92.72M | 103.90M | 71.82M | 22.70M | 6.00M | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -381.69M | -362.67M | -150.72M | -650.50M | 379.50M | |||
| Income Tax | 3.97M | 3.59M | 2.89M | -300.00K | 1.90M | |||
| Net Income | -385.66M | -366.25M | -153.61M | -650.20M | 377.70M | |||
| EBITDA | -455.24M | -447.31M | -202.70M | -649.00M | 391.50M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -4.52 | -4.34 | -1.94 | -8.36 | 4.70 | |||
| Non GAAP EPS | -4.52 | -4.37 | -1.96 | -8.37 | 4.42 | |||
| Statistics | ||||||||
| Profit Margin | -1023.64% | -981.54% | -41.38% | -54183.33% | 41.28% | |||
| Operating Profit Margin | -1259.20% | -1250.38% | -59.95% | -56100.00% | 40.82% | |||
All data in USD